Hongqing Zhao

Dr. Hongqing Zhao


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2025 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
LSLingchang Shi
Lingchang Shi
YHYing He
Ying He
YLYujun Lian
Yujun Lian
JLJie Luo
Jie Luo
XZXuan Zhu
Xuan Zhu
HZHongqing Zhao
Hongqing Zhao

6 August 2025 in Biochemical Pharmacology
Verified
Journal Article
Closed access
TWTianyu Wang
Tianyu Wang
LSLingchang Shi
Lingchang Shi
QLQiaoyun Luo
Qiaoyun Luo
YWYuhong Wang
Yuhong Wang
HZHongqing Zhao
Hongqing Zhao

19 May 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
LSLingchang Shi
Lingchang Shi
JWJingya Wei
Jingya Wei
RCRonglin Chen
Ronglin Chen
YLYang Liu
Yang Liu
MZManshu Zou
Manshu Zou
HZHongqing Zhao
Hongqing Zhao
Background: Anxious depression is a prevalent affective disorder characterized by typical depressive symptoms accompanied by persistent anxiety. Increasing evidence suggests that mitochondrial oxidative stress and neuroinflammation contribute to its onset and progression; however, the precise mechanisms linking these processes remain elusive. Methods: A rat model of anxious depression was established via chronic restraint stress combined with corticosterone administration. Integrated proteomic and transcriptomic analyses were performed to profile differentially expressed molecules in the hippocampus, with key signaling pathways validated by Western blot and qPCR. A Mito-TEMPO intervention group was introduced to evaluate the role of mitochondrial oxidative stress, involving behavioral tests, mitochondrial ultrastructure and reactive oxygen species (ROS) detection, and analysis of autophagy-, inflammation-, and apoptosis-related markers. Additionally, in vitro experiments were conducted using TXNIP siRNA knockdown in BV2 microglia to further verify the role of TXNIP. Results: Proteomic and transcriptomic profiling identified dysregulation of inflammatory-, synaptic-, and mitophagy-related pathways in the hippocampus of model rats, with prominent upregulation of TXNIP and activation of the NLRP3 inflammasome. Model rats exhibited excessive mitochondrial ROS (mtROS) accumulation, suppressed PINK1/Parkin-mediated mitophagy, neuronal injury, and anxiety- and depression-like behaviors. Mito-TEMPO intervention alleviated these pathological changes by scavenging mtROS, restoring mitophagy, inhibiting TXNIP/NLRP3 inflammasome activation, and reducing neuronal apoptosis. In vitro , TXNIP knockdown in BV2 microglia attenuated LPS-induced NLRP3 inflammasome activation and pro-inflammatory cytokine secretion, thereby protecting HT22 neurons from inflammatory injury. Conclusion: Our findings suggest that the ROS/TXNIP/NLRP3 signaling axis mediates the crosstalk between mitochondrial oxidative stress and neuroinflammation, thereby contributing to the pathogenesis of anxious depression.

25 November 2025 in Cardiovascular Drugs and Therapy
Verified
Journal Article
Closed access
SHShiyi Huang
Shiyi Huang
XHXiangchang He
Xiangchang He
JDJie Dai
Jie Dai
TZTing Zou
Ting Zou
HZHongqing Zhao
Hongqing Zhao
GXGuangming Xu
Guangming Xu

26 September 2026 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
RCRonglin Chen
Ronglin Chen
JLJie Luo
Jie Luo
KHKexin He
Kexin He
DYDongmei Yang
Dongmei Yang
HZHongqing Zhao
Hongqing Zhao
Depression-related disorders remain major clinical challenges, and increasing evidence suggests that estrogen receptor (ER) signaling is involved in processes relevant to depression, including neuroinflammation, synaptic plasticity, neurotransmission, and stress regulation. Natural products and Traditional Chinese Medicine (TCM) formulas have attracted growing attention because of their multi-target regulatory effects on ER-related pathways. This narrative review summarizes ER-related pharmacological evidence of natural products and TCM preparations in depression-related disorders, with emphasis on flavonoids, stilbenes, lignans, and terpenoids. Evidence was interpreted according to depression relevance and the directness of ER involvement. Current findings suggest that ERα, ERβ, and G protein-coupled estrogen receptor (GPER) are implicated in depression-related regulation through partially overlapping and context-dependent mechanisms, with their relative roles varying according to brain region, cell type, endocrine state, ligand properties, and exposure. Some natural products have been reported to exhibit SERM-like or context-dependent estrogenic activity; however, receptor-subtype selectivity and tissue-selective safety remain incompletely established. Across separate experimental studies, TCM formulas have been associated with ER-related signaling alterations together with modulation of 5-HT, BDNF, NLRP3, and neuroendocrine pathways, supporting mechanistic convergence rather than experimentally demonstrated synergy. Collectively, subtype- and context-dependent ER modulation represents a hypothesis-generating framework for evaluating natural product-based candidates in depression-related disorders, while currently available evidence does not establish selective ER modulation or clinically validated tissue-specific safety advantages.